Responses
Regular and young investigator award abstracts
Cellular therapies
129 A novel CAR conducting antigen-specific JAK-STAT signals demonstrates superior antitumor effects with minimal undesired non-specific activation
Compose a Response to This Article
Other responses
No responses have been published for this article.
